Cystatin M/E knockdown by lentiviral delivery of shRNA impairs epidermal morphogenesis of human skin equivalents

Exp Dermatol. 2012 Nov;21(11):889-91. doi: 10.1111/exd.12022.

Abstract

The protease inhibitor cystatin M/E (CST6) regulates a biochemical pathway involved in stratum corneum homeostasis, and its deficiency in mice causes ichthyosis and neonatal lethality. Cystatin M/E deficiency has not been described in humans so far, and we did not detect disease-causing mutations in the CST6 gene in a large number of patients with autosomal recessive congenital ichthyosis, who were negative for mutations in known ichthyosis-associated genes. To investigate the phenotype of CST6 deficiency in human epidermis, we used lentiviral delivery of short hairpin RNAs that target CST6 in a 3D reconstructed skin model. Surprisingly, CST6 deficiency did not cause an ichthyosis-like phenotype, but prevented the development of a multilayered epidermis. From this study, we conclude that CST6 deficiency may be incompatible with normal human foetal development.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cystatin M / genetics*
  • Cystatin M / physiology
  • Epidermal Cells
  • Epidermis / drug effects
  • Epidermis / growth & development*
  • Gene Knockdown Techniques
  • Humans
  • Ichthyosis / pathology
  • Lentivirus / genetics*
  • Models, Biological
  • Morphogenesis / drug effects
  • Morphogenesis / genetics*
  • Phenotype
  • RNA, Small Interfering / genetics*
  • RNA, Small Interfering / pharmacology
  • Skin, Artificial
  • Tissue Scaffolds

Substances

  • CST6 protein, human
  • Cystatin M
  • RNA, Small Interfering